Overview
Status
Active
Registry date
2017-05-08
Share capital
5,000.00 PLN
Registered address
ul. Hurtowa 2, 62-510 Konin, Poland
Electronic delivery address
AE:PL-79516-98940-VJJWU-21
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 36 days early.
- 202513/07/2026
- 202427/06/2025
- 202308/07/2024
- 202223/06/2023
- 202117/05/2022
- 202001/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 793.31kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -23.35kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 801.54kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 187.00kMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
TAB-Pharm has been an NFZ healthcare provider since 2015. In 2022 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2022 |
|---|---|---|---|
| Provision of medical devices | śląskie | 1 | USD 0.00 |
Authorized Representatives
Julia Szyszyńska – Management Board Member
Paweł Tabisz – President of the Management Board
Piotr Szmyt – Management Board Member
Manner of representation
For making declarations of will on behalf of the company with respect to property rights and obligations, each member of the management board is authorized to act independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 4,186PLN 4,186 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 28, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,197$1,197 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o. | $16,601,428.28 | apimex.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Rutkiewicz I Wspólnicysp. j. | – | aptekapoznan.com |
FAQ
The main business activity of Tab-Pharm focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on May 8, 2017.
The headquarters is located at: ul. Hurtowa 2, 62-510 Konin.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $687,943 in 2024, which is an increase of 4.3% compared to 2023.
No, the company recorded a net loss of $821 in 2024. For comparison, in 2023 the loss was $5,909, meaning the company reduced its loss by 86.8%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $510,395 in 2024, representing 76% of all operating expenses.
Last updated: 2026-10-07
